BIM Offers University Tools and Capabilities that Support Their O&M and Facilities Management

Lina Stinnett, J. E. Dunn Construction
Matt Meyer, J. E. Dunn Construction

Objective:
The objective is to demonstrate how BIM, created for a university research lab facility, can be successfully leveraged by an owner beyond initial construction.

Project:
University of Colorado at Boulder (UCB)
Jennie Smoly Caruthers Biotech Bldg
Description: 338,000 sqft multi-disciplined research facility, bringing scientists from eight departments into one collaborative and exploratory environment

Abstract:
The team will describe their approach for using BIM specific to flexible lab design, first to aid in a collaborative construction coordination process that met the University's goals and objectives, and finally to leverage the three-dimensional information-rich model data beyond the construction phase, for this exciting new lab facility.

The UCB's Biotech Bldg provided a unique opportunity to maximize the value of BIM far beyond bldg completion. By combining a progressive FM staff and collaborative construction and design team members, the collective group had the ability to drive innovation, using technology, to another level.

When construction of the biotech facility began, the construction team met with key FM staff regularly to review specific areas of the lab bldg visually in the BIM model and get their feedback and buy-in. Input was provided on access to their systems (panels, valves, mechanical equipment) and the team would work to accommodate their needs. The lab equipment vendors provided BIM models, which aided the owner staff in understanding how the equipment would be moved into and fit within the overall space. The owner staff was brought into the site office and always involved as we coordinated in BIM from one area to the next, making sure all of the key areas in the lab facility were being built to meet their goals and objectives.

After BIM coordination of the biotech facility finished, the team offered the University various ways to access and use these data-rich models. Some of the FM staff installed BIM software on their computers, and with training from us, are able to utilize the models for maintenance purposes. The robust hyperlinked digital as-built documents created for the facility also provided links to the final BIM models so the owner would have quick access to the visual information when needed.

Suggested Presentation Topics:

  • Innovative Ways to Leverage BIM and Technology during construction of a Lab Facility
  • Use of the Models after construction for building management
  • Owner Training for BIM use beyond building construction

Audience Benefits:

  1. Description of the use of BIM and technology during construction of the Biotech Bldg
  2. How BIM can be used after bldg. completion
  3. Ways to tie BIM into final deliverables

Learning Objectives

  • Describe the use of BIM and technology during construction of the Jennie Smoly Caruthers Biotech Bldg
  • Explain how BIM can be utilized by an owner after building completion
  • Identify various ways to incorporate Building Information Models into final deliverables for the owner

Biographies:

Lina Stinnett is the Regional BIM Director for JE Dunn's West Region Division. Lina holds a bachelor degree in Architecture from the University of Kansas, is a LEED Accredited Professional, and an Associate AIA (American Institute of Architects) member. Lina's focus is getting involved with project teams early on, setting them up with the BIM and technology to be successful, then making sure those tools are implemented and followed through construction to facilities management for the owner.

Matt Meyer is a senior project manager for JE Dunn Construction's Science and Technology Group in Denver, Colorado. Matt holds a Bachelor of Science in Construction Management from Colorado State University and is a LEED Accredited Professional. Matt has over 28 years of experience and has built facilities for entities such as the University of Colorado, Sandia Nat'l Labs, the CDC, Amgen and the Corps of Engineers. Matt is a current member of I2SL and ISPE.

 

Note: I2SL did not edit or revise abstract or biography text. Abstracts and biographies are displayed as submitted by the author(s).